Diseases & Disorders
(G123)
IRS Verified
DX Registered
990 on File
MICHAEL R PASCUCCI LUNG CANCER ASSOCIATION
Financial strength (30%)
60/100
Reliability (20%)
50/100
Effectiveness (25%)
73/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$40K
Total Revenue
$30K
Total Expenses
$51K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
99.7%
Fundraising Efficiency
110.5%
Operating Reserve
20.52x
Liability-to-Asset
0.0%
Revenue Diversification
103.8%
Compared with Peers
FY 2023
Compared with 2,111 similar organizations
(United States, Diseases & Disorders, under $100K in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
99.7% | 78.1% |
P10P90
|
Top quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
110.5% | 45.5% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
20.5 mo | 23.2 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
103.8% | 99.9% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-4.4% | -2.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-24.8% | 1.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
24.3% | 11.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $40K | $30K | $51K | 99.7% | — |
| 2022 | $42K | $40K | $42K | 99.9% | — |
| 2021 | $75K | $75K | N/A | — | 1 |
| 2020 | $14K | $50 | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.